dm+d
370215003
Medicine Compliance Aid Stability
MigardMenarini Pharmaceuticals International SRL
Menarini Pharmaceuticals International SRL
Migard
Tablets f/c 2.5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
12 September 2022
Lactation Safety Information
Sumatriptan
Long half-life increases risk of accumulation in breastfed infants
No published evidence of safety
5HT1-receptor agonist for treatment of acute migraine
18 September 2020